Wave Life Sciences (WVE) Capital Expenditures Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.32% |
| Dec 31, 2025 | -14.89% |
| Sep 30, 2025 | 30.71% |
| Jun 30, 2025 | 17.61% |
| Mar 31, 2025 | -22.23% |
| Dec 31, 2024 | -42.31% |
| Sep 30, 2024 | -3.81% |
| Jun 30, 2024 | -49.60% |
| Mar 31, 2024 | -3.87% |
| Dec 31, 2023 | -36.55% |
| Sep 30, 2023 | -43.33% |
| Jun 30, 2023 | -48.15% |
| Mar 31, 2023 | -15.92% |
| Dec 31, 2022 | -58.93% |
| Sep 30, 2022 | 15.54% |
| Jun 30, 2022 | -39.81% |
| Mar 31, 2022 | -41.27% |
| Dec 31, 2021 | -67.23% |
| Sep 30, 2021 | 25.09% |
| Jun 30, 2021 | -24.46% |
| Mar 31, 2021 | -10.21% |
| Dec 31, 2020 | -10.50% |
| Sep 30, 2020 | -33.74% |
| Jun 30, 2020 | -17.74% |
| Mar 31, 2020 | 102.58% |
| Dec 31, 2019 | 34.54% |